SCHEMBL3756959

SCHEMBL3756959

COc1cc(CCC(=O)CCCC(=O)O)cc(OC)c1O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 7/20 0.71
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C8 P10632 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2B6 P20813 1/20 0.52
CYP2C19 P33261 1/20 0.52
NFKB1 P19838 2/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
TNKS2 Q9H2K2 2/20 0.50
LTA4H P09960 1/20 0.50
OR51E2 Q9H255 1/20 0.49
AKR1B1 P15121 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA3 P07451 1/20 0.45
PKM P14618 1/20 0.45
CA4 P22748 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL490990 0.87 ALOX5 (0.69) ALOX5NFKB1NFKB2RELATNKS2
SCHEMBL27043019 0.86 ALOX5 (0.59) ALOX5NFKB1NFKB2RELATNKS2
SCHEMBL2852406 0.84 ALOX5 (0.70) ALOX5CYP1A2CYP3A4CYP2C8CYP2C9
SCHEMBL20940489 0.83 ALOX5 (1.00) ALOX5CYP1A2CYP3A4CYP2C8CYP2C9
SCHEMBL25363485 0.81 ALOX5 (0.60) ALOX5NFKB1NFKB2RELATNKS2
SCHEMBL28104847 0.81 CYP3A4 (0.65) ALOX5CYP1A2CYP3A4CYP2C8CYP2C9
SCHEMBL29832717 0.77 ALOX5 (0.64) ALOX5CYP1A2CYP3A4CYP2C9CYP2B6
SCHEMBL14311297 0.77 ALOX5 (0.56) ALOX5NFKB1NFKB2RELATNKS2
SCHEMBL6143465 0.77 ALOX5 (0.56) ALOX5NFKB1NFKB2RELATNKS2
SCHEMBL17306533 0.76 ALOX5 (0.55) ALOX5NFKB1NFKB2RELATNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389569-B2 Polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same UNIVERSITE JOSEPH FOURIER (FR) 2013-03-05 US disclosed
US-20100298422-A1 NOVEL POLYSPIRANE COMPOUNDS, APPLICATION THEREOF IN THE TREATMENT OF MALARIA OR TOXOPLASMOSIS AND METHOD FOR PREPARING SAME UNIVERSITE JOSEPH FOURIER (FR) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298422-A1 NOVEL POLYSPIRANE COMPOUNDS, APPLICATION THEREOF IN THE TREATMENT OF MALARIA OR TOXOPLASMOSIS AND METHOD FOR PREPARING SAME FLOT1, PHOSPHO1, GPAA1 ALOX5 1649/4885CYP1A2 2026/4885CYP3A4 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.